Prescription drug · ANDA
Finasteride NDC 63187-265
Finasteride 5 mg/1 · Tablet, Film coated · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63187-265-10 | 63187026510 | 10 TABLET, FILM COATED in 1 BOTTLE (63187-265-10)Marketed from Feb 11, 2022 | |
| 63187-265-30 | 63187026530 | 30 TABLET, FILM COATED in 1 BOTTLE (63187-265-30)Marketed from Nov 3, 2014 | |
| 63187-265-60 | 63187026560 | 60 TABLET, FILM COATED in 1 BOTTLE (63187-265-60)Marketed from Jul 3, 2017 | |
| 63187-265-90 | 63187026590 | 90 TABLET, FILM COATED in 1 BOTTLE (63187-265-90)Marketed from Jul 3, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Finasteride
- Generic name (nonproprietary)
- finasteride
- Active ingredients
- Finasteride — 5 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090121
- Marketing start
- Listing expires
- Other FDA classes
- 5-alpha Reductase Inhibitors (Mechanism)
- Identifiers
- Product ID 63187-265_8438d683-b2a2-476b-8511-e2b74829e90bSPL ID 8438d683-b2a2-476b-8511-e2b74829e90bSPL set ID e9ea2f77-11c3-4dbf-bdc4-d1b0e7437990RxCUI 310346UNII 57GNO57U7GUPC 0363187265304
- Pharmacologic class
- 5-alpha Reductase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N463187026510followed by a unit qualifier and the quantityPackage 63187-0265-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Finasteride, is a 5α-reductase inhibitor, indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to ( 1.1 ): • Improve symptoms • Reduce the risk of the need for surgery including transurethral resection of the prostate (TURP) and prostatectomy. Finasteride administered in combination with the alpha-blocker doxazosin is indicated to reduce the risk of symptomatic progression of BPH (a confirmed ≥4 point increase in American Urological Association (AUA) symptom score) ( 1.2 ). Limitations of Use : Finasteride is not approved for the prevention of prostate cancer ( 1.3 ). 1.1 Monotherapy Finasteride tablets USP, 5 mg are indicated for the…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 090121
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Finasteride | Finasteride 5 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 71335-0433 |
| Finasteride | Finasteride 5 mg/1 | Tablet, Film coatedOral | NuCare Pharmaceuticals,Inc. | 68071-3354 |
| Finasteride | Finasteride 5 mg/1 | Tablet, Film coatedOral | NuCare Pharmaceuticals,Inc. | 68071-3380 |
| Finasteride | Finasteride 5 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 71335-1634 |
| Finasteride | Finasteride 5 mg/1 | Tablet, Film coatedOral | Accord Healthcare, Inc. | 16729-090 |
| Finasteride | Finasteride 5 mg/1 | Tablet, Film coatedOral | Atlantic Biologicals Corps | 17856-0090 |